We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

110 hedge funds and large institutions have $248M invested in Dynavax Technologies in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

669% more call options, than puts

Call options by funds: $777K | Put options by funds: $101K

6% less funds holding

Funds holding: 117110 (-7)

12% less capital invested

Capital invested by funds: $282M → $248M (-$33.5M)

31% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 36

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
110
Holders Change
-7
Holders Change %
-5.98%
% of All Funds
3.19%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
10
Increased
25
Reduced
36
Closed
16
Calls
$777K
Puts
$101K
Net Calls
+$676K
Net Calls Change
-$182K
Name Holding Trade Value Shares
Change
Change in
Stake
EARNEST Partners
101
EARNEST Partners
Georgia
$12K
BlackRock
102
BlackRock
New York
$11K +$1.77K +123 +19%
Canada Life
103
Canada Life
Manitoba, Canada
$10K
Barclays
104
Barclays
United Kingdom
$9K +$6.62K +459 +99%
Royal Bank of Canada
105
Royal Bank of Canada
Ontario, Canada
$7K +$2.88K +200 +74%
EFSCE
106
Enterprise Financial Services Corp (EFSC)
Missouri
$4K -$2.9K -201 -41%
MWP
107
MYCIO Wealth Partners
Pennsylvania
$4K
GAM
108
Gemmer Asset Management
California
$1K
Manulife (Manufacturers Life Insurance)
109
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$247 -$4.96K -344 -2%
BCPEM
110
Bain Capital Public Equity Management
Massachusetts
-$8.44M -527,494 Closed
CCM
111
Cadence Capital Management
Massachusetts
-$1.06M -66,314 Closed
Neuberger Berman Group
112
Neuberger Berman Group
New York
-$497K -31,050 Closed
Nomura Holdings
113
Nomura Holdings
Japan
-$319K -20,273 Closed
AGM
114
Alpine Global Management
New York
-$160K -10,000 Closed
Principal Financial Group
115
Principal Financial Group
Iowa
-$138K -8,638 Closed
Fidelity Investments
116
Fidelity Investments
Massachusetts
-$126K -7,851 Closed
Citadel Advisors
117
Citadel Advisors
Florida
-$95.9K -6,651 Closed
NCCM
118
Nine Chapters Capital Management
New Jersey
-$94K -5,890 Closed
AL
119
Airain Ltd
Guernsey
-$80K -5,022 Closed
VFA
120
Virtus Fund Advisers
Connecticut
-$36K -2,243 Closed
BJ
121
BlackRock Japan
Japan
-$35K -2,187 Closed
SLG
122
Stanley-Laman Group
Pennsylvania
-$24K -1,500 Closed
Jacobs Levy Equity Management
123
Jacobs Levy Equity Management
New Jersey
-$21K -1,310 Closed
TC
124
TFS Capital
Pennsylvania
-$21K -1,302 Closed
GSC
125
Ground Swell Capital
South Carolina
-$9K -583 Closed

DVAX Hedge Fund Activity: Q3 2014 in Review

110 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2014, worth a combined $248M — down 12% from $282M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of DVAX and 10 opened new positions — a net loss of 6 holders — while 36 trimmed existing stakes and 25 added.

The largest buyer was Westfield Capital Management, adding an estimated $5.78M. The largest seller was Bain Capital Public Equity Management, exiting entirely with an estimated $8.44M sold.

  • 110 institutional investors held Dynavax Technologies (DVAX) as of Q3 2014, down from 117 in Q2 2014.
  • Funds reported $248M of Dynavax Technologies stock for Q3 2014, down 12% quarter-over-quarter.
  • 10 funds opened new Dynavax Technologies positions in Q3 2014 and 16 closed out, a net change of -6 holders.
  • The largest Dynavax Technologies buyer in Q3 2014 was Westfield Capital Management, an estimated $5.78M added.
  • The largest Dynavax Technologies seller in Q3 2014 was Bain Capital Public Equity Management, an estimated $8.44M sold.

Based on aggregated 13F filings for Q3 2014.